| Schedule of reconciliation to the consolidated net income (loss) |
The table below presents the financial information used by the CODM to assess performance, which reconciles to the consolidated net income (loss):
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, |
|
(In thousands) |
|
2025 |
|
|
2024 |
|
Total revenue |
|
$ |
88,632 |
|
|
$ |
77,499 |
|
Less: |
|
|
|
|
|
|
Cost of products sold |
|
|
8,842 |
|
|
|
10,971 |
|
Amortization of acquired intangible assets |
|
|
6,475 |
|
|
|
6,440 |
|
Selling and marketing |
|
|
8,071 |
|
|
|
9,263 |
|
General and administrative |
|
|
19,420 |
|
|
|
21,142 |
|
Research and development - External services |
|
|
3,051 |
|
|
|
1,649 |
|
Research and development - Internal expenses |
|
|
1,345 |
|
|
|
2,229 |
|
Changes in fair values of equity method investments, net |
|
|
13,549 |
|
|
|
(35,342 |
) |
Changes in fair values of equity and long-term investments, net |
|
|
65,299 |
|
|
|
13,335 |
|
Interest and dividend income |
|
|
(4,538 |
) |
|
|
(4,399 |
) |
Interest expense |
|
|
4,711 |
|
|
|
5,851 |
|
Other expense, net |
|
|
996 |
|
|
|
1,236 |
|
Income tax expense, net |
|
|
7,995 |
|
|
|
8,592 |
|
Consolidated net income (loss) |
|
$ |
(46,584 |
) |
|
$ |
36,532 |
|
|